Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-10-24

Clinical Trial Update: The Effect of Zoledronic Acid on Patients With Osteoarthritis of the Hip [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial investigates the effect of zoledronic acid in patients with hip osteoarthritis; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Vestre Viken Hospital Trust | Conditions: Osteoarthritis, Hip | Phase 3 | Status: UNKNOWN